SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EYES Second Sight-Eyeglasses for the Blind help them see
EYES 4.140-5.0%Aug 30 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Julius Wong7/14/2017 10:19:57 PM
   of 99
 
Medicare reimbursement for Second Sight's Argus may drop 19% next year
  • The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a new reimbursement code for Second Sight Medical's (NASDAQ: EYES) Argus II Retinal Prosthesis System in 2018 that would, if enacted, reduce reimbursement to ~$122K from $150K this year.
  • The company says it will comment on the proposed change to CMS in the coming months. The final rule will be released in mid-Q4.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext